[Skip to Content]
[Skip to Content Landing]
January 2, 1967


JAMA. 1967;199(1):38. doi:10.1001/jama.1967.03120010082020

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


Are you for or against motherhood and sunshine? Are you opposed to clean air? These rhetorical questions are an integral part of the new game called "Good Guys and Bad Guys in Medical Legislation." The object of this governmental exercise is to color everything in blacks and whites so that the opponents of a particular bill can be immediately identified as enemies of progress. Recently, legislators were asked to consider the effective distribution of such drugs as amphetamines or barbiturates. Surely an impartial and candid debate of the many facets of this problem would be encouraged by a bill whose title correctly identifies the topic as one of the control of the manufacture and distribution of depressant and stimulant drugs. Instead, the Madison Avenue approach dictates that the act shall be called "The Drug Abuse Control Amendments of 1965." The focus thus is not upon an honest and comprehensive evaluation